ADRA2B
MOLECULAR TARGETadrenoceptor alpha 2B
ADRA2B (adrenoceptor alpha 2B) is targeted by 74 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ADRA2B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 74 compounds. Use the BiohacksAI search to explore all ADRA2B modulators.
About ADRA2B as a Drug Target
ADRA2B (adrenoceptor alpha 2B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 74 compounds with documented ADRA2B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ADRA2B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.